NCT00170625View on ClinicalTrials.gov

Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2005

Conditions
Ovarian Cancer
Interventions
DRUG

Hycamtin

Topotecan: 1,0 mg/m²/d, day 1-3; q21d Carboplatin: AUC 5 on day 3 after Topotecan, q21d

All Listed Sponsors
lead

North Eastern German Society of Gynaecological Oncology

OTHER

NCT00170625 - Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer | Biotech Hunter | Biotech Hunter